Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E Carwile LeRoy, MD.

Richard M Silver1

  • 1Division of Rheumatology & Immunology, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 822, Charleston, SC 29425, USA.

Rheumatic Diseases Clinics of North America
|November 16, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis.

Annals of the rheumatic diseases·2026
Same author

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

ACR open rheumatology·2025
Same author

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study.

Rheumatology (Oxford, England)·2025
Same author

Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of concept.

Journal of scleroderma and related disorders·2025
Same author

Atomic-scale Control of Tunneling in Donor-based Devices.

Communications physics·2025
Same author

Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension.

Journal of scleroderma and related disorders·2024
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Dr. E. Carwile LeRoy pioneered systemic sclerosis (SSc) research, noting excess collagen production by scleroderma fibroblasts and proposing a vascular pathogenesis. His work significantly advanced understanding of this autoimmune disease.

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • E. Carwile LeRoy, M.D. was a key figure in systemic sclerosis (SSc) research.
  • His training included mentorship from prominent clinical investigators.
  • Dr. LeRoy established a renowned Division of Rheumatology & Immunology.

Purpose of the Study:

  • To highlight the contributions of Dr. E. Carwile LeRoy to the field of systemic sclerosis.
  • To recognize his seminal observations and hypotheses regarding SSc pathogenesis.
  • To acknowledge the impact of his established division on SSc research and clinical care.

Main Methods:

  • Review of Dr. LeRoy's pioneering research contributions.
  • Analysis of his key observations on collagen production in scleroderma fibroblasts.
Keywords:
Medical University of South CarolinaRaynaud phenomenonSclerodermaSystemic sclerosis (SSc)

Related Experiment Videos

  • Examination of his proposed vascular hypothesis for SSc pathogenesis.

    • Main Results:

    • Dr. LeRoy identified the over-production of collagen by scleroderma fibroblasts as a significant finding.
    • He proposed a vascular hypothesis for the pathogenesis of systemic sclerosis.
    • The division he founded is recognized globally for SSc research.

    Conclusions:

    • Dr. LeRoy's work laid foundational understanding for systemic sclerosis.
    • His research continues to influence the study and treatment of scleroderma.
    • The Division of Rheumatology & Immunology at MUSC remains a leading center for SSc research.